Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
XENE

Xenon Pharmaceuticals

, AMGN

Amgen

$170.77

1.39 (0.82%)

14:29
11/17/17
11/17
14:29
11/17/17
14:29
Periodicals
Xenon higher as CNBC's Tirrell reports on nonaddictive pain medicines »

Six drug companies are…

XENE

Xenon Pharmaceuticals

AMGN

Amgen

$170.77

1.39 (0.82%)

RHHBY

Roche

$28.90

0.165 (0.57%)

BIIB

Biogen

$313.98

3.7 (1.19%)

RGEN

Repligen

$33.73

1.12 (3.43%)

VRTX

Vertex

$147.94

-0.72 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 23

    Dec

  • 03

    Feb

  • 23

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

ACOR

Acorda Therapeutics

$17.25

0.25 (1.47%)

, HLUYY

Lundbeck

$56.38

0.36 (0.64%)

07:06
11/17/17
11/17
07:06
11/17/17
07:06
Hot Stocks
Acorda announces $53M in royalty monetization transactions »

Acorda Therapeutics…

ACOR

Acorda Therapeutics

$17.25

0.25 (1.47%)

HLUYY

Lundbeck

$56.38

0.36 (0.64%)

BIIB

Biogen

$313.98

3.7 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Thursday
PFE

Pfizer

$35.56

0.2 (0.57%)

17:00
11/16/17
11/16
17:00
11/16/17
17:00
Hot Stocks
Pfizer confirms FDA approval for Sutent in renal cell carcinoma »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 14

    Dec

TBPH

Theravance Biopharma

$28.88

1.76 (6.49%)

, GSK

GlaxoSmithKline

$35.21

0.325 (0.93%)

16:14
11/16/17
11/16
16:14
11/16/17
16:14
Hot Stocks
Theravance Biopharma: EC grants marketing authorization for Trelegy Ellipta »

Theravance Biopharma…

TBPH

Theravance Biopharma

$28.88

1.76 (6.49%)

GSK

GlaxoSmithKline

$35.21

0.325 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PFE

Pfizer

$35.52

0.16 (0.45%)

16:00
11/16/17
11/16
16:00
11/16/17
16:00
Hot Stocks
FDA expands approval of Pfizer's Sutent »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 14

    Dec

SHPG

Shire

$140.03

0.76 (0.55%)

15:52
11/16/17
11/16
15:52
11/16/17
15:52
Hot Stocks
Shire treatment of pediatric UC patients granted FDA orphan status »

Shire's treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHPG

Shire

$140.03

0.76 (0.55%)

, RHHBY

Roche

$28.73

-0.12 (-0.42%)

13:49
11/16/17
11/16
13:49
11/16/17
13:49
Recommendations
Shire, Roche analyst commentary at Cantor Fitzgerald »

Roche's black box…

SHPG

Shire

$140.03

0.76 (0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

SHPG

Shire

$140.03

0.76 (0.55%)

, RHHBY

Roche

$28.73

-0.12 (-0.42%)

13:13
11/16/17
11/16
13:13
11/16/17
13:13
Recommendations
Shire, Roche, Bioverativ analyst commentary at RBC Capital »

Roche approval neutral to…

SHPG

Shire

$140.03

0.76 (0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

BIVV

Bioverativ

$55.18

0.79 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

MXWL

Maxwell

$4.75

-0.27 (-5.38%)

, SU

Suncor

09:40
11/16/17
11/16
09:40
11/16/17
09:40
Options
Unusually active option classes on open November 16th »

Unusual total active…

MXWL

Maxwell

$4.75

-0.27 (-5.38%)

SU

Suncor

BBY

Best Buy

MOMO

Momo

$30.59

1.4 (4.80%)

ROKU

Roku

$39.32

2.37 (6.41%)

MRK

Merck

EWZ

MSCI Brazil Index

PBR

Petrobras

SVXY

ProShares Short VIX Short-Term Futures

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 05

    Dec

  • 14

    Dec

  • 02

    Feb

PFE

Pfizer

$35.36

-0.02 (-0.06%)

, NVS

Novartis

$82.60

-0.43 (-0.52%)

07:28
11/16/17
11/16
07:28
11/16/17
07:28
Periodicals
Pfizer, Novartis agree to UK price cuts for breast cancer drugs, Reuters reports »

Pfizer (PFE) and Novartis…

PFE

Pfizer

$35.36

-0.02 (-0.06%)

NVS

Novartis

$82.60

-0.43 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.